JSPR
Jasper Therapeutics Inc.
$2.80
-$0.04(-1.41%)
26
Overall
--
Value
18
Tech
34
Quality
Market Cap
$47.46M
Volume
95.01K
52W Range
$2.27 - $26.05
Target Price
$14.29
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | -- | -- | $9.0M | -- | $9.0M | $8.3M | ||
| Total Revenue | -- | -- | $9.0M | -- | $9.0M | $8.3M | ||
| COST OF GOODS SOLD | ||||||||
| Cost of Revenue | -- | $-7.0K | -- | -- | -- | -- | ||
| GROSS PROFIT | ||||||||
| Gross Profit | -- | $7.0K | $9.0M | -- | $9.0M | $8.3M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $136.3K | $20.7M | $36.8M | $51.2M | $68.9M | $76.2M | ||
| Research & Development | -- | $15.9M | $25.4M | $34.6M | $51.8M | $55.8M | ||
| Research Expense | -- | $15.9M | $25.4M | $34.6M | $51.8M | $55.8M | ||
| Selling, General & Administrative | $136.3K | $4.8M | $11.4M | $16.6M | $17.1M | $20.4M | ||
| Selling & Marketing Expenses | -- | -- | $436.0K | $2.7M | -- | -- | ||
| General & Administrative Expenses | $136.3K | $4.8M | $11.4M | $16.6M | $17.1M | $20.4M | ||
| Salaries & Wages | -- | -- | -- | -- | $5.2M | $6.6M | ||
| Depreciation & Amortization | -- | -- | -- | -- | $1.1M | $1.4M | ||
| Depreciation & Amortization | -- | -- | -- | -- | $1.1M | $1.4M | ||
| Amortization | -- | -- | $400.0K | $1.0M | -- | -- | ||
| Other Operating Expenses | -- | $-235.0K | $-576.0K | $-894.0K | $-698.0K | $-639.0K | ||
| OPERATING INCOME | ||||||||
| Operating income | $-136.3K | $-20.7M | $-36.8M | $-51.2M | $-68.9M | $-76.2M | ||
| EBITDA | $18.3K | $-20.7M | $-36.5M | $-36.4M | $-76.9M | $-84.8M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | -- | $111.0K | $80.0K | -- | $246.0K | -- | ||
| Intinc | -- | -- | -- | $2.2M | $5.2M | $5.1M | ||
| Net Non-Operating Interest Income/Expense | -- | $-111.0K | $-80.0K | $2.2M | $5.2M | $5.1M | ||
| Other Income/Expense | $-154.6K | $-383.1K | $-6.2M | $-13.5M | $821.0K | $88.0K | ||
| Other Special Charges | $154.6K | $383.1K | $6.2M | $13.5M | $-821.0K | $-88.0K | ||
| SPECIAL ITEMS | ||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | $36.8M | $34.3M | ||
| Special Income Charges | -- | $-10.9M | -- | -- | $-36.8M | $-34.3M | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $18.3K | $-20.7M | $-36.8M | $-37.7M | $-78.0M | $-86.2M | ||
| Pre-Tax Income | $18.3K | $-31.7M | $-30.6M | $-37.7M | $-64.5M | $-71.3M | ||
| INCOME TAX | ||||||||
| Tax Provision | $16.2K | $38.5K | $-6.4M | $-7.9M | $-13.5M | $-15.0M | ||
| NET INCOME | ||||||||
| Net Income | $2.0K | $-31.7M | $-30.6M | $-37.7M | $-64.5M | $-71.3M | ||
| Net Income (Continuing Operations) | $2.0K | $-31.7M | $-30.6M | $-37.7M | $-64.5M | $-71.3M | ||
| Net Income (Discontinued Operations) | $2.0K | $-31.7M | $-30.6M | $-37.7M | $-64.5M | $-71.3M | ||
| Net Income (Common Stockholders) | $2.0K | $-31.7M | $-30.6M | $-37.7M | $-64.5M | $-71.3M | ||
| Normalized Income | -- | -- | -- | -- | -- | $-52.0M | ||
| TOTALS | ||||||||
| Total Expenses | $136.3K | $928.4K | $36.8M | $-51.2M | $68.9M | $76.2M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $1.3M | $1.0M | $1.1M | $36.5M | $10.4M | $14.6M | ||
| Average Shares Outstanding (Diluted) | $1.3M | $1.0M | $266.0K | $36.5M | $10.4M | $14.6M | ||
| Shares Outstanding | $16.3M | $1.3M | $3.8M | $109.4M | $16.3M | $16.3M | ||
| Basic EPS | -- | -- | $-26.9 | $-1.03 | $-6.18 | $-4.89 | ||
| Basic EPS (Continuing Operations) | -- | -- | $-26.9 | $-1.03 | $-6.18 | $-4.89 | ||
| Diluted EPS | $-0.10 | $0.10 | $-26.9 | $-1.03 | $-6.18 | $-4.89 | ||
| Diluted EPS (Continuing Operations) | $-0.10 | $0.10 | -- | $-1.03 | $-6.18 | $-4.89 | ||
| OTHER METRICS | ||||||||
| Earnings from equity interest | -- | -- | -- | -- | $700.0K | -- | ||
| Earnings From Equity Interest Net Of Tax | -- | -- | -- | -- | $700.0K | -- | ||
| Other Gand A | $136.3K | $4.8M | $11.4M | $16.6M | $17.1M | $20.4M | ||
| Rent And Landing Fees | -- | -- | -- | $-100.0K | -- | -- | ||
| Othspecchg | -- | $10.9M | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | $36.8M | $34.3M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | JSPR | $2.80 | -1.4% | 95.01K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Jasper Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW